Zhixin Z.

Zhixin Z. has a diverse work experience in the pharmaceutical industry. They started at Boehringer Ingelheim as an intern in 2009. In 2010, they moved on to Novartis where they worked as a Senior Scientist, focusing on formulation development for TABRECTA® (capmatinib) and solid characterization for APIs and excipients. In 2012, Zhixin joined Purdue Pharma L.P. as a Senior Research Scientist and later became a Lead Scientist, working on various research projects. In 2016, they transitioned to Bristol Myers Squibb as a Senior Research Investigator I and eventually became a Senior Research Investigator II, specializing in formulation and preformulation development and drug stability risk assessment. Finally, in 2019, Zhixin joined Assembly Biosciences, Inc. as the Director of Drug Product Development and Manufacture, and later became the Senior Director and Head of Drug Product Development.

Zhixin Z. has a Bachelor of Science degree in Chemistry from Lanzhou University. After completing their undergraduate studies, they pursued a Master of Science degree in Analytical Chemistry from the same university. Zhixin Z. then furthered their education and obtained a Ph.D. in Pharmaceutics from the University of Iowa.